Biomarkers May Predict Rx Response in Diabetic Macular Edema

Biomarkers from the anterior chamber of the eye help predict response to ranibizumab, which could spare patients repeated injections with an ineffective agent, a small trial suggested.
Medscape Medical News

Full Story →